Souhaitez-vous accéder aux communiqués récents ?

Reference is made to the private placement of 3,253,370 new shares towards Bomi Framroze (the "Private Placement") in Hofseth BioCare ASA, as announced on 23 March 2020. The share capital increase...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE...

Styret i Hofseth BioCare ASA har i dag 20. mars 2020 godkjent årsrapporten for 2019. Årsrapporten inkludert ESG-rapport (kapittel 5) for 2019 ligger vedlagt. For ytterligere informasjon, vennligst...

Today, 20 March 2020, the Board of Directors approved the Annual Report for 2019. Please find the Annual Report, including the ESG Report (chapter 5) for 2019 attached. For further...

Ålesund/London, 17.03.2020 Hofseth BioCare (“HBC”) has today signed a comprehensive distribution contract with Prinova Europe (“Prinova”). The agreement is a European exclusive distribution...

James Berger, Head of Investor Relations & Strategy in Hofseth BioCare ASA, has today 26.02.2020 purchased 30,000 shares at an average price of NOK 6,73 per share. Following this transaction,...

Hofseth BioCare ASA ("HBC") had operating revenues of NOK 11.1m (NOK 14.5m) in the fourth quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 8.4m (NOK 9.9m) in the period. Operational profit...

Today, Hofseth BioCare ASA (“HBC”) has signed a new credit facility of up to NOK 37 million with SpareBank 1 Nordvest for working capital needs related to future sales contracts. The credit line is...

On January 1, 2020, a merger between Yokohama Reito Co., Ltd. ("Yokorei") and its wholly owned subsidiary, Alliance Seafoods Inc., the latter being the owner of 40,951,333 shares in Hofseth Biocare...

Ålesund/Miami, November 1st, 2019 Atlantic Sapphire AS (“Atlantic Sapphire”, ASA-ME) and Hofseth Biocare ASA (“HBC”; OSE:HBC) announce today the signing of a Letter of Intent to establish a joint...